IPAB Will Make CMS More Relevant In Parallel Reviews With FDA, Former Official Gottlieb Predicts
Executive Summary
BALTIMORE – Decisions by the soon-to-be-created Independent Payment Advisory Board could make CMS participation in parallel review of drugs with FDA much more meaningful than it would otherwise be, assuming the health care reform law remains intact, former CMS and FDA official Scott Gottlieb said.
You may also be interested in...
Romney’s Health Care Advisors Drawn From CMS Trenches
Team reunites officials who had served at HHS during the George W. Bush administration.
Former CMS Officials Call For Cost To Be Factored Into Coverage Decisions
Four former CMS officials are recommending authority to use cost-related analysis and policies be added to the tools the agency can use as a means of improving the quality and efficiency of Medicare.
Former CMS Officials Call For Cost To Be Factored Into Coverage Decisions
Four former CMS officials are recommending authority to use cost-related analysis and policies be added to the tools the agency can use as a means of improving the quality and efficiency of Medicare.